Concepedia

Christine Hanzis

CH

Statistics

Publications

1

Citations

74

H-Index

1

Active since

2011

Affiliations

BioBridges (United States)(Current)

Christine Hanzis is an author at BioBridges (United States) specializing in therapy response assessment, treatment response prognosis, and immunogenetics.

Publications per year

2011–2011

1

Publications

1

Attainment of complete/very good partial response following rituximab‐based therapy is an important determinant to progression‐free survival, and is impacted by polymorphisms in <i>FCGR3A</i> in Waldenstrom macroglobulinaemia

Steven P. Treon, Guang Yang, Christine Hanzis et al. · British Journal of Haematology · 2011 · 74 citations

, , +15

1–1 of 1